SFEBES2025 Poster Oral Presentations Neuroendocrinology and Pituitary (4 abstracts)
Characterisation of the acromegalic arthropathy in patients <50 years of age
Nikolaos Kyriakakis 1 , Megan Heague 1 , Sophie Hebden 1 , Nawaz Safdar 1 , David S. McLaren 1 , Alberto S. Tresoldi 2 , Lithgow Kirstie 2 , Urwyler Sandrine 2 , Chetna Varsani 3 , Akbar Shahzad 4 , McLoughlin Katie 5 , Katarzyna Adeniji 5 , Tara Kearney 5 , William M. Drake 3 , Thozhukat Sathyapalan 4 , Claire E. Higham 6 , Niki Karavitaki 2 , Julie Lynch 1 & Robert D. Murray 1
1Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom; 2University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom; 3St Bartholomew’s Hospital, London, United Kingdom; 4Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom; 5Northern Care Alliance NHS Foundation Trust, Salford, United Kingdom; 6The Christie NHS Foundation Trust, Manchester, United Kingdom
Background: The acromegalic arthropathy is a disease-specific, progressive, degenerative arthropathy. Degenerative arthropathies such as osteoarthritis are infrequent below the age of 50 years. We characterised the prevalence of acromegalic arthropathy in patients <50 years of age.
Methods: We undertook a multicentre, cross-sectional study, utilising validated questionnaires in patients with acromegaly, aiming to examine distribution of arthropathy, severity of pain, and treatment modalities employed.
Results: Of the total cohort, 107/411 patients were <50 years of age (median 41, 18-50 years; 47F; 44.9% with active disease) and 304 were >50 years (median 65, 51-88 years; 163F; 35.5% with active disease). The most painful joint was similar to the overall cohort (lower back [20.8%], knees [16.0%] and hips [12.3%]). The median number of painful joints was 5 (range 0-25). 36.4% and 10.3% of those <50 years complained of moderate or severe joint pain respectively, compared with 45.7% and 14.1% of those >50 years. 56% and 29.9% of patients aged <50 years were taking at least one or two regular analgesics respectively, whereas the corresponding percentages for those >50 years were 61.4% and 37.2%. The most frequently used analgesics in patients aged ≤50 years were paracetamol (39.3%), oral non-steroidal anti-inflammatory drugs (NSAIDs; 29.9%), topical NSAIDs (9.3%), and codeine (15.0%). Four individuals were taking more potent opioids and 6 atypical analgesics. 16.8% of these patients had received at least one joint injection, however only three patients (2.8%) had undergone joint replacement therapy for a total of five joints (2 shoulders, 2 hips and 1 knee). In those aged >50 years 29.9% had received at least one joint injection and 22.0% (n = 67/304) had at least one joint replaced.
Conclusions: Patients with acromegaly aged <50 years have significant arthropathy burden characterised by pain, requirement for analgesics and joint injections, however joint replacement was uncommon.
Volume 109
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more